PNC Financial Services Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Sell |
1,422
-719
| -34% | -$98.8K | ﹤0.01% | 2217 |
|
|
2025
Q1 | $386K | Buy |
2,141
+461
| +27% | +$83.1K | ﹤0.01% | 1710 |
|
|
2024
Q4 | $263K | Buy |
1,680
+36
| +2% | +$5.64K | ﹤0.01% | 2008 |
|
|
2024
Q3 | $299K | Buy |
1,644
+158
| +11% | +$28.8K | ﹤0.01% | 1905 |
|
|
2024
Q2 | $273K | Buy |
1,486
+565
| +61% | +$104K | ﹤0.01% | 1928 |
|
|
2024
Q1 | $164K | Buy |
921
+601
| +188% | +$107K | ﹤0.01% | 2316 |
|
|
2023
Q4 | $39.7K | Sell |
320
-100
| -24% | -$12.4K | ﹤0.01% | 3083 |
|
|
2023
Q3 | $48.7K | Buy |
420
+48
| +13% | +$5.57K | ﹤0.01% | 2973 |
|
|
2023
Q2 | $43.7K | Buy |
372
+124
| +50% | +$14.6K | ﹤0.01% | 3141 |
|
|
2023
Q1 | $19.9K | Hold |
248
| – | – | ﹤0.01% | 3497 |
|
|
2022
Q4 | $19.6K | Buy |
248
+70
| +39% | +$5.55K | ﹤0.01% | 3479 |
|
|
2022
Q3 | $12K | Buy |
+178
| New | +$12K | ﹤0.01% | 3670 |
|
|
2022
Q2 | – | Sell |
-28
| Closed | -$2K | – | 4617 |
|
|
2022
Q1 | $2K | Buy |
28
+26
| +1,300% | +$1.86K | ﹤0.01% | 4203 |
|
|
2021
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4534 |
|